سعر فيوسي 2% مرهم 30 جم 2025

Sodium fusidate 2% ointment, 30 g tube, by Pharopharma (Egypt); a topical antibiotic.

• Primary and secondary skin infections caused by sensitive strains of Staphylococcus aureus, Streptococcus species and Corynebacterium minutissimum, e.g. impetigo contagiosa, superficial folliculitis, sycosis barbae, paronychia, erythrasma, and secondary infection of eczematoid or contact dermatitis and of skin lesions such as cuts.Population: Adults and childrenelectronic medicines compendium (eMC), UK

• Uncommon: dermatitis (including contact dermatitis, eczema), rash, pruritus, erythema, application-site pain/burning and irritation. Rare: hypersensitivity, angioedema, urticaria, blisters, conjunctivitis.International label, same formulation · electronic medicines compendium (eMC), UK

• Hypersensitivity to fusidic acid/sodium fusidate or to any excipient.International label, same formulation · electronic medicines compendium (eMC), UK

• Bacterial resistance among Staphylococcus aureus has been reported with topical fusidic acid; extended or recurrent use may increase the risk of resistance and of contact sensitisation.International label, same formulation · electronic medicines compendium (eMC), UK
• Use with care near the eyes (the UK product excipients may cause conjunctival irritation; the Egyptian excipients are not known).International label, same formulation · electronic medicines compendium (eMC), UK
• The UK ointment contains wool fat (lanolin), cetyl alcohol and butylated hydroxytoluene, which may cause local skin reactions; paraffin-containing products on dressings or clothing are a fire hazard (keep away from flames). Egyptian excipients not confirmed.International label, same formulation · electronic medicines compendium (eMC), UK

• Systemically administered medicinal productsNo interaction studies performed; interactions are considered minimal because systemic absorption of topical fusidic acid is negligible.electronic medicines compendium (eMC), UK

• No effects during pregnancy are anticipated because systemic exposure to topically applied fusidic acid is negligible; can be used during pregnancy.International label, same formulation · electronic medicines compendium (eMC), UK
• No effects on the breast-fed infant are anticipated; can be used during breastfeeding, but avoid applying the product on the breast.International label, same formulation · electronic medicines compendium (eMC), UK

• Sodium fusidate: Inhibits bacterial protein synthesis by binding elongation factor G (EF-G) on the ribosome, preventing translocation; mainly active against Gram-positive bacteria such as Staphylococcus aureus.